trending Market Intelligence /marketintelligence/en/news-insights/trending/UlYshYdUoUXnaRMThCBdeQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Versant Ventures pulls in US$700M across 2 funds

Street Talk Episode 68 - As many investors zig away from bank stocks, 2 vets in the space zag toward them

Street Talk Episode 66 - Community banks tap the debt markets while the getting is good

Street Talk Episode 67 - Veteran investor tabs Mick Mulvaney to help with latest financial stock-focused fund

Street Talk Episode 65 - Deferral practices trap US bank portfolios in purgatory

Versant Ventures pulls in US$700M across 2 funds

Versant Venture Management LLC, also known as Versant Ventures, raised a total of US$700 million across two funds.

The biotechnology-focused investment firm's primary global fund, Versant Venture Capital VII LP, garnered US$600 million, while its Canadian companion fund, Versant Voyageurs I, collected US$100 million.

Fund VII will inject capital into 20 or more biotechnology companies across the U.S., Canada and Europe. Voyageurs I will invest in five to eight Canadian startups.

Both funds received commitments from new and existing sponsors. Fonds de solidarité FTQ was one of the anchor investors in Voyageurs I, together with BDC Capital, Caisse de dépôt et placement du Québec and historical investor Teralys Capital.